Document Classification

Section Type: RESULTS

Text: LDL-C significantly reduction from baseline (4. 18 0. 54) mmol/L to (3. 44 0. 61) mmol/L (-17. 7 %, P < 0. 05) at week 3 and (3. 35 0. 39) mmol/L (-19. 9 %, P < 0. 05) at week 6 in the treatment group, whereas in placebo group from (4. 11 0. 54) mmol/L at baseline to (3. 47 0. 60) mmol/L (-15. 57 %, P < 0. 05) and (3. 61 0. 39) mmol/L (-12. 17 %, P < 0. 05) at week 3 and week 6, respectively.